Madison, WI, United States of America

Nathan Feirer

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Promega Corporation. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathan Feirer: Innovator in Nucleic Acid Modifying Reagents

Introduction

Nathan Feirer is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification reactions. His innovative work has implications for various applications in research and diagnostics.

Latest Patents

Nathan Feirer holds 1 patent for his invention titled "Nucleic acid modifying reagents and uses thereof." This patent encompasses compounds, compositions, and methods designed for nucleic acid amplification reactions. Specifically, it provides compounds that selectively bind to nucleic acids from non-viable cells, enhancing the accuracy of viability PCR (vPCR) applications.

Career Highlights

Feirer is currently employed at Promega Corporation, a leading company in the life sciences industry. His work at Promega has allowed him to further develop his innovative ideas and contribute to advancements in molecular biology.

Collaborations

Throughout his career, Nathan has collaborated with esteemed colleagues, including Michael Scurria and Said A Goueli. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Nathan Feirer is a distinguished inventor whose work in nucleic acid modifying reagents has the potential to impact various scientific fields. His contributions continue to advance the understanding and application of molecular biology techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…